Plasma trials are continuing, but doctors are unsure how to select COVID-19 survivors who are most likely to have strong antibody responses.
from WebMD Healthhttps://img.webmd.com/dtmcms/live/webmd/consumer_assets/site_images/article_thumbnails/news/2019/02_2019/blood_plasma/1800x1200_blood_plasma.jpg https://ift.tt/37Pjx0C
via IFTTT
0 comments:
Post a Comment